News
There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...
Looking Ahead The FDA’s full-scale adoption of AI technology represents a leap forward in regulatory oversight. By ...
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after completing a new generative AI pilot for scientific reviewers. Supposedly ...
Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results